CWAM
Columbia Wanger Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $67M | Sell |
1,444,584
-151,750
| -10% | -$7.04M | 1% | 13 |
|
|
2017
Q3 | $85M | Buy |
1,596,334
+231,900
| +17% | +$12.4M | 1.26% | 10 |
|
|
2017
Q2 | $84.7M | Buy |
1,364,434
+126,609
| +10% | +$7.86M | 1.21% | 6 |
|
|
2017
Q1 | $83.9M | Buy |
1,237,825
+62,209
| +5% | +$4.22M | 1.18% | 7 |
|
|
2016
Q4 | $82.7M | Sell |
1,175,616
-81,655
| -6% | -$5.74M | 1.16% | 11 |
|
|
2016
Q3 | $89.2M | Buy |
1,257,271
+393,879
| +46% | +$27.9M | 1.17% | 11 |
|
|
2016
Q2 | $42.2M | Sell |
863,392
-97,753
| -10% | -$4.78M | 0.49% | 91 |
|
|
2016
Q1 | $60.9M | Sell |
961,145
-150,421
| -14% | -$9.52M | 0.66% | 59 |
|
|
2015
Q4 | $125M | Sell |
1,111,566
-141,048
| -11% | -$15.8M | 1.25% | 14 |
|
|
2015
Q3 | $121M | Sell |
1,252,614
-1,081,559
| -46% | -$104M | 0.96% | 20 |
|
|
2015
Q2 | $239M | Buy |
2,334,173
+89,463
| +4% | +$9.16M | 1.54% | 9 |
|
|
2015
Q1 | $139M | Buy |
2,244,710
+914,143
| +69% | +$56.8M | 0.76% | 30 |
|
|
2014
Q4 | $58.4M | Sell |
1,330,567
-460,515
| -26% | -$20.2M | 0.29% | 114 |
|
|
2014
Q3 | $101M | Sell |
1,791,082
-2,100
| -0.1% | -$119K | 0.47% | 68 |
|
|
2014
Q2 | $77.4M | Sell |
1,793,182
-2,300
| -0.1% | -$99.3K | 0.31% | 115 |
|
|
2014
Q1 | $81.9M | Buy |
+1,795,482
| New | +$81.9M | 0.32% | 111 |
|